GlaxoSmithKline
GlaxoSmithKline to stop paying doctors for product promotion
17 Dec 2013
The move comes after the biggest drugmaker in the UK stood accused of making corrupt payments to doctors and officials to boost its drug sales in China
Glaxo announces open offer to hike stake in Indian arm
16 Dec 2013
Betting on rising drug demand, GlaxoSmithKline Plc has earmarked around $1 billion to raise its stake in its Indian subsidiary to 75 per cent
GSK sells thrombosis drugs to Aspen for $1.13 billion
01 Oct 2013
The sale comes a month after London-based GSK agreed to sell its Lucozade and Ribena soft drink brands to Japan's Suntory Beverages for £1.35 billion
Japan's Suntory to pay $2.11 bn for GSK’s Lucozade, Ribena soft drink brands
10 Sep 2013
Japan's Suntory Beverage & Food Ltd yesterday agreed to buy the Lucozade and Ribena brands from GlaxoSmithKline Plc, for £1.35 billion in order to expand its soft drinks portfolio in Europe
India revokes patent of GSK’s breast cancer drug Tykerb
02 Aug 2013
The Intellectual Property Appellate Board, however, upheld the patent granted to the drug’s active pharmaceutical ingredient `lapatinib`
China accuses GSK of bribery, raising prices and tax fraud
11 Jul 2013
Employees of GSK in China have confessed to bribing doctors, hospitals, government officials and others to prescribe the company's medicines to increase drug sales, China's ministry of public security said in a website statement
